SCHEMBL13865716

SCHEMBL13865716

Cc1nc(N2CCC(NC(=O)Nc3cccc4c(C)nccc34)CC2)ccc1C(C)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CLK2 P49760 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
CSNK2A1 P68400 1/20 0.42
STK3 Q13188 1/20 0.42
HIPK4 Q8NE63 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
TRPV1 Q8NER1 5/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
EPHX1 P07099 1/20 0.39
CCNC P24863 4/20 0.39
CDK8 P49336 4/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA4 P22748 2/20 0.39
CA7 P43166 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13865713 0.91 PAK1 (0.41) PAK1KDM4ECLK2GSK3AGSK3B
SCHEMBL13865711 0.89 DRD2 (0.45) PAK1KDM4ECLK2GSK3AGSK3B
SCHEMBL13865723 0.87 CCNC (0.43) PAK1KDM4ECLK2GSK3AGSK3B
SCHEMBL13865685 0.87 CLK2 (0.43) PAK1KDM4ECLK2GSK3AGSK3B
SCHEMBL13865715 0.85 TRPV1 (0.54) PAK1KDM4ETRPV1SIGMAR1
SCHEMBL13865714 0.85 TRPV1 (0.43) PAK1KDM4ETRPV1TRPM8SIGMAR1
SCHEMBL13865719 0.82 TRPV1 (0.44) PAK1KDM4ETRPV1TRPM8
SCHEMBL13865717 0.81 PAK1 (0.46) PAK1KDM4ETRPV1SIGMAR1EPHX1
SCHEMBL13865722 0.81 TRPV1 (0.45) PAK1KDM4ETRPV1SIGMAR1CCNC
SCHEMBL13865721 0.80 PAK1 (0.47) PAK1KDM4ETRPV1TRPM8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7528151-B2 Heterocyclic urea derivatives for the treatment of pain GLAXO GROUP LIMITED (GB) 2009-05-05 US disclosed